1 of 1
SENATE DOCKET, NO. 1434 FILED ON: 1/16/2025
SENATE . . . . . . . . . . . . . . No. 1167
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Joan B. Lovely
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act to protect nonhuman primate infants in research institutions and product testing facilities.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :Joan B. LovelySecond EssexMichael D. BradySecond Plymouth and Norfolk2/6/2025Michael O. MooreSecond Worcester3/6/2025 1 of 3
SENATE DOCKET, NO. 1434 FILED ON: 1/16/2025
SENATE . . . . . . . . . . . . . . No. 1167
By Ms. Lovely, a petition (accompanied by bill, Senate, No. 1167) of Joan B. Lovely, Michael
D. Brady and Michael O. Moore for legislation to protect nonhuman primate infants in research
institutions and product testing facilities. The Judiciary.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act to protect nonhuman primate infants in research institutions and product testing facilities.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Chapter 272 of the General Laws is hereby amended by inserting after
2Section 80G the following new section:-
3 Section 80G1/2.
4 (a) As used in this section, the following words shall have the following meanings unless
5the context clearly requires otherwise:
6 “Commissioner”, the commissioner of the Massachusetts Department of Public Health.
7 “Contract testing facility”, a partnership, corporation, association, or other legal
8relationship that tests cosmetics or other products, product formulations, chemicals, or
9ingredients. 2 of 3
10 “Product testing facility”, a facility that is using animals for the testing of consumer
11products, including, but not limited to, cosmetics, pesticides, medical devices, food additives,
12and ingredients for use in such products.
13 “Research institution”, any facility employing nonhuman primates in scientific,
14investigation, experiment or instruction or for the testing of drugs or medicines licensed by the
15commissioner of public health under section 174D.
16 “Nonhuman primate (NHP)”, any primate species except humans, including but not
17limited to rhesus macaques, long-tailed (i.e., crab-eating or cynomolgus) macaques, stump-tailed
18macaques pig-tailed macaques, squirrel monkeys, owl monkeys, African green monkeys,
19marmosets, baboons, spider monkeys, capuchin monkeys, and titi monkeys.
20 (b) A research institution or product testing facility that utilizes infant NHPs in
21experiments shall not remove or separately house the infants from their respective biological
22mothers for the purposes of research, experimentation, or product testing.
23 (c) An infant NHP may be temporarily removed or separately housed from its mother
24only for the medical welfare of either or both NHPs. Upon removal or separation, psychological
25and physical distress shall be minimized for both NHPs and reunion of the NHPs shall not be
26delayed unless medically necessary.
27 (d) The prohibition in subsection (b) shall begin at the time of the infant NHP’s birth
28through his/her first twelve (12) months of life.
29 (e) The commissioner shall promulgate regulations to implement, enforce, and administer
30this section. 3 of 3
31 SECTION 2. The commissioner shall promulgate regulations to implement this Act no
32later than ninety (90) days following its passage. Section 1 shall take effect 90 days after passage
33of this Act and Section 2 shall take effect upon passage of this Act.